Form 4: Contineum Therapeutics Director Olivia C. Ware Granted Stock Options
SEC Form 4
Director Olivia C. Ware receives 3,700 stock options from Contineum Therapeutics under the 2024 Equity Incentive Plan.
Summary
- Olivia C. Ware, a director of Contineum Therapeutics, Inc. (CTNM), was granted 3,700 stock options on May 24, 2024.
- The options were granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended.
- The exercise price of the options is $15.76 per share.
- One-third of the option shares vest on April 5, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to continuous service.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common form of compensation for directors, aligning their interests with the long-term performance of the company. This grant is part of Contineum Therapeutics' Non-Employee Director Compensation Program.
Comparison to Industry Standards
- Stock option grants to directors are a standard practice in the biotechnology industry.
- The size and vesting schedule of the grant are typical for companies of Contineum Therapeutics' size and stage of development.
- Comparable companies such as Biohaven Pharmaceuticals (before its acquisition by Pfizer) and Neurocrine Biosciences also utilize stock options as part of their director compensation packages.
Stakeholder Impact
- Shareholders: The grant aligns director interests with shareholder value.
- Employees: The grant is part of a broader compensation program.
- Director: The grant provides an incentive for long-term commitment and performance.
Key Dates
| Date | Description |
|---|---|
| 05/24/2024 | Date of transaction: Stock options granted to Olivia C. Ware |
| 04/05/2025 | Vesting start date: One-third of the option shares vest |
| 05/23/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.